HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Virginia A McNally Selected Research

Therapeutics

3/2010Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Virginia A McNally Research Topics

Disease

1Disease Progression
03/2010
1Breast Neoplasms (Breast Cancer)
03/2010
1Neoplasms (Cancer)
01/2002

Drug/Important Bio-Agent (IBA)

1ErbB Receptors (EGF Receptor)IBA
03/2010
1pertuzumabIBA
03/2010
1Trastuzumab (Herceptin)FDA Link
03/2010
1quinone (benzoquinone)IBA
01/2002

Therapy/Procedure

1Therapeutics
03/2010
1Drug Therapy (Chemotherapy)
01/2002